Kriti Nutrients Limited has formally notified BSE Limited that it does not qualify as a Large Corporate under the SEBI circular reference SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated 19th October, 2023, pertaining to fund raising by issuance of debt securities by large entities. The disclosure was filed on 9th May, 2026, and was submitted by Company Secretary & Compliance Officer Raj Kumar Bhawsar, along with Chief Financial Officer Mohan Gehlot.

Regulatory Disclosure Details

The filing was made in compliance with the applicability criteria outlined in the SEBI circular and is accompanied by Annexure A, the prescribed format for initial disclosure by entities identified as Large Corporates. Kriti Nutrients has confirmed that it does not meet the threshold criteria defined under the framework, and has requested BSE to place the information on record and make it available on the exchange's website for the benefit of investors and members of the company.

The key details submitted as part of the Annexure A disclosure are presented below:

Company Background

Kriti Nutrients Limited is headquartered at Brilliant Sapphire, 801-804, 8th Floor, Plot No. 10, Sch. 78-II, Vijay Nagar, Indore – 452 010 (M.P.), India. Its registered office is located at Mehta Chamber, 34 Siyaganj, Indore – 452007 (M.P.), India, and its manufacturing facility is situated at Industrial Area No. 3, AB Road, Dewas (MP), India.

Key Takeaways

• Kriti Nutrients confirms non-applicability of the SEBI Large Corporate framework as per the circular dated 19th October, 2023.
• The company reported NIL long-term outstanding borrowings as on 31st March, 2026.
• The highest credit rating during the previous financial year was A- (Single A Minus) assigned by CARE Ratings for supported bank borrowings.
• The disclosure was duly signed by the Company Secretary & Compliance Officer and the Chief Financial Officer, dated 8th May, 2026 and filed on 9th May, 2026.

Kriti Nutrients Limited's Board of Directors, at its meeting held on 5 May 2026, approved the standalone and consolidated audited financial results for the quarter and year ended 31 March 2026. The results were subsequently published in Chautha Sansar and Business Standard on 7 May 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board also decided not to recommend any final dividend on equity shares of Re 1/- each for the financial year 2025-26, noting that an interim dividend of ₹3/- per share had already been declared and paid.

Quarterly Performance

Kriti Nutrients delivered a notable improvement in quarterly profitability and operating performance on a year-on-year basis. Q4 EBITDA rose to 93M rupees from 60.9M rupees in the year-ago quarter, while the EBITDA margin improved to 3.65% from 3.04% over the same period. Standalone revenue from operations for the quarter stood at ₹25,523.21 lakhs, compared to ₹20,005.31 lakhs in the corresponding quarter of the previous year and ₹22,430.73 lakhs in the preceding quarter ended 31 December 2025. Standalone net profit for the quarter rose to ₹619.05 lakhs from ₹494.93 lakhs in Q4 FY25. On a consolidated basis, net profit for the quarter was ₹636.06 lakhs, compared to ₹491.89 lakhs in the year-ago quarter.

Financial Performance: Revenue and Profitability

Kriti Nutrients reported strong revenue growth for the full year, with standalone total income from operations rising to ₹92,948.36 lakhs from ₹74,210.06 lakhs in the previous year. Net profit after tax for the year on a standalone basis stood at ₹3,384.05 lakhs, compared to ₹3,702.38 lakhs in the prior year. The consolidated net profit for the year, inclusive of the share in associate's profit, stood at ₹3,390.13 lakhs compared to ₹3,699.35 lakhs previously. The equity share capital remained unchanged at ₹501.04 lakhs (face value of ₹1/- each). The following table presents the key standalone and consolidated financial highlights:

Balance Sheet Highlights

As at 31 March 2026, standalone total assets stood at ₹27,266.27 lakhs, up from ₹23,782.93 lakhs as at 31 March 2025. Total equity increased to ₹22,906.63 lakhs from ₹21,189.06 lakhs. Cash and cash equivalents rose significantly to ₹4,625.45 lakhs from ₹170.78 lakhs. On the consolidated basis, total assets were ₹27,272.20 lakhs and total equity was ₹22,912.56 lakhs.

Cash Flow Summary

Net cash from operating activities for the year stood at ₹6,428.73 lakhs on both a standalone and consolidated basis, compared to ₹3,195.79 lakhs in the previous year. Net cash used in investing activities was ₹934.98 lakhs, while net cash used in financing activities was ₹1,039.08 lakhs. The net increase in cash and cash equivalents for the year was ₹4,454.67 lakhs, with closing cash and cash equivalents of ₹4,625.45 lakhs against an opening balance of ₹170.78 lakhs.

Board Decisions: Dividend and Leadership

The board confirmed that no final dividend is recommended for FY2025-26, as an interim dividend of ₹3/- per share had already been declared at the board meeting held on 8 November 2025 and paid on 15 November 2025. On leadership matters, the board approved, subject to member approval at the General Meeting, the re-appointment of Mr. Shiv Singh Mehta (DIN: 00023523) as Chairman and Managing Director for a period of three years with effect from 12 January 2027. The board also approved the re-designation of Mr. Saurabh Singh Mehta (DIN: 00023591) as Joint Managing Director for the remaining period from 5 May 2026 to 31 July 2027, and his subsequent re-appointment as Whole-time Director designated as Joint Managing Director for a period of three years with effect from 1 August 2027, both subject to member approval.

Regulatory and Audit Disclosures

The financial results were reviewed by the Audit Committee at its meeting held on 4 May 2026 and subsequently taken on record by the Board of Directors on 5 May 2026. The statutory auditors, M Mehta & Company, Chartered Accountants (Firm Registration No. 000957C), expressed an unmodified audit opinion on both the standalone and consolidated financial results. The company operates in a single business segment — Oil Seed Extraction and Refining — as per Ind AS 108. The consolidated financial statements include the results of associate company Kriti Industries (India) Limited, in which Kriti Nutrients holds 6.24% of share capital and exercises significant influence. The disclosure was filed with both the National Stock Exchange of India Limited and BSE Limited, and was signed by Raj Kumar Bhawsar, Company Secretary and Compliance Officer.

Source: None/Company/INE798K01010/c59aa163-7596-4186-8baf-ab93c40b9474.pdf